| scholarly article | Q13442814 |
| P2093 | author name string | Catia Sternini | |
| James J Galligan | |||
| P2860 | cites work | G-protein-coupled receptor heterodimerization modulates receptor function | Q24603239 |
| β-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons | Q24632390 | ||
| Structure-based discovery of opioid analgesics with reduced side effects | Q26331003 | ||
| The role of naloxegol in the management of opioid-induced bowel dysfunction | Q28072039 | ||
| The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence | Q28260467 | ||
| Incomplete cross tolerance and multiple mu opioid peptide receptors | Q31887588 | ||
| Opiate binding sites in the cellular immune system: expression and regulation | Q32062116 | ||
| Electrocardiographic Abnormalities, Malignant Ventricular Arrhythmias and Cardiomyopathy Associated with Loperamide Abuse | Q33167512 | ||
| Multiple mechanisms of fast excitatory synaptic transmission in the enteric nervous system | Q33951852 | ||
| Lubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse. | Q34028142 | ||
| Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal | Q34104454 | ||
| Classes of enteric nerve cells in the guinea-pig small intestine | Q34123444 | ||
| Receptors and transmission in the brain-gut axis: potential for novel therapies. III. Mu-opioid receptors in the enteric nervous system | Q34283883 | ||
| A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine | Q34321618 | ||
| Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment | Q34323667 | ||
| Mu and delta receptors belong to a family of receptors that are coupled to potassium channels | Q34336041 | ||
| Morphine decreases enteric neuron excitability via inhibition of sodium channels. | Q34428483 | ||
| Loperamide Abuse Associated With Cardiac Dysrhythmia and Death | Q34524773 | ||
| Morphine Induces μ Opioid Receptor Endocytosis in Guinea Pig Enteric Neurons Following Prolonged Receptor Activation | Q34551407 | ||
| Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins | Q34568617 | ||
| Beta-arrestin-biased ligands at seven-transmembrane receptors | Q34654662 | ||
| Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities | Q34939624 | ||
| Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance. | Q35264421 | ||
| Activation of μ opioid receptors modulates inflammation in acute experimental colitis. | Q35510067 | ||
| Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice | Q35601042 | ||
| Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. | Q35760524 | ||
| The role of β-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract | Q35776850 | ||
| Opioids increase potassium conductance in submucous neurones of guinea-pig caecum by activating delta-receptors | Q35886903 | ||
| Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig. | Q36065514 | ||
| The narcotic bowel syndrome: clinical features, pathophysiology, and management | Q36136622 | ||
| Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice | Q36227327 | ||
| Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract | Q44346815 | ||
| Noradrenaline, somatostatin and opioids inhibit activity of single HVA/N-type calcium channels in excised neuronal membranes | Q44608923 | ||
| Stoichiometry of neurally induced VIP release, NO formation, and relaxation in rabbit and rat gastric muscle | Q45098725 | ||
| Opiate activation of potassium conductance in myenteric neurons: inhibition by calcium ion. | Q46927792 | ||
| Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence | Q57394739 | ||
| Potassium conductance increased by noradrenaline, opioids, somatostatin, and G-proteins: whole-cell recording from guinea pig submucous neurons | Q68086838 | ||
| Inhibition of calcium currents by noradrenaline, somatostatin and opioids in guinea-pig submucosal neurones | Q68172366 | ||
| The effect of quinidine, a strong P-glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxegol | Q85844612 | ||
| Eluxadoline for Irritable Bowel Syndrome with Diarrhea | Q87120880 | ||
| Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain | Q36253231 | ||
| Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters | Q36307818 | ||
| Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist | Q36382976 | ||
| Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. | Q36591603 | ||
| Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction | Q36741881 | ||
| Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanyl | Q36780862 | ||
| "I just wanted to tell you that loperamide WILL WORK": a web-based study of extra-medical use of loperamide | Q36788050 | ||
| Enhanced Sensitivity of α3β4 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation | Q36947767 | ||
| Morphine tolerance in the mouse ileum and colon | Q36952367 | ||
| Agonist-selective endocytosis of mu opioid receptor by neurons in vivo | Q37390918 | ||
| A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia | Q37416417 | ||
| Mu and kappa opioids inhibit transmitter release by different mechanisms | Q37681064 | ||
| Loperamide and P-glycoprotein inhibition: assessment of the clinical relevance | Q37770261 | ||
| Methylnaltrexone for the treatment of opioid-induced constipation | Q38069607 | ||
| Molecular physiology of enteric opioid receptors | Q38248063 | ||
| P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery | Q38259301 | ||
| Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons | Q38354363 | ||
| Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS. | Q38675489 | ||
| Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications | Q38911748 | ||
| Loperamide-Related Deaths in North Carolina | Q38913158 | ||
| Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation | Q39750331 | ||
| Ethanol inhibits gastric acid secretion in rats through increased AMP-kinase activity. | Q39917033 | ||
| Pharmacology of Antidiarrheal Drugs | Q40135927 | ||
| Comparison of opioid receptor distributions in the rat ileum | Q40372543 | ||
| Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine. | Q40458253 | ||
| Opioid and opiate immunoregulatory processes. | Q41174967 | ||
| Opioid inhibition of synaptic transmission in the guinea-pig myenteric plexus | Q41837757 | ||
| Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic | Q42091393 | ||
| Naloxegol for opioid-induced constipation in patients with noncancer pain | Q43318363 | ||
| Opioids inhibit neuromuscular transmission in circular muscle of human and baboon jejunum | Q43702633 | ||
| Responses of myenteric S neurones to low frequency stimulation of their synaptic inputs | Q43962674 | ||
| Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons. | Q44106312 | ||
| How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? | Q44332145 | ||
| Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon | Q44335421 | ||
| Chemical coding of neurons expressing delta- and kappa-opioid receptor and type I vanilloid receptor immunoreactivities in the porcine ileum | Q44337563 | ||
| Regulatory role of enteric kappa opioid receptors in human colonic motility | Q44338151 | ||
| Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured interstitial cells of Cajal from mouse small intestine | Q44339979 | ||
| Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions | Q44340489 | ||
| Neurochemically distinct classes of myenteric neurons express the mu-opioid receptor in the guinea pig ileum | Q44340668 | ||
| Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine | Q44342837 | ||
| The opioid system in the gastrointestinal tract | Q44346649 | ||
| P304 | page(s) | 363-378 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Handbook of experimental pharmacology | Q26841924 |
| P1476 | title | Insights into the Role of Opioid Receptors in the GI Tract: Experimental Evidence and Therapeutic Relevance | |
| P478 | volume | 239 |
| Q92471819 | 4,8-Dimethylcoumarin Inhibitors of Intestinal Anion Exchanger slc26a3 (Downregulated in Adenoma) for Anti-Absorptive Therapy of Constipation |
| Q48099588 | Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial |
| Q90002332 | Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response |
| Q64954113 | Pathophysiology and management of opioid-induced constipation: European expert consensus statement. |
| Q56927411 | Pathophysiology, diagnosis, and management of opioid-induced constipation |
| Q92099255 | Potential neuro-immune therapeutic targets in irritable bowel syndrome |
| Q64974535 | Recent advances in understanding and managing diverticulitis. |
Search more.